Lataa...
Alzheimer’s disease drug development: old problems require new priorities
Alzheimer’s disease (AD) clinical drug development and patient care depend on rating instruments, research designs and methods, and translations of clinical trial (CT) results into the clinic without support from standardized protocols able to control (i) random measurement error intrusions into obs...
Tallennettuna:
| Julkaisussa: | CNS Neurol Disord Drug Targets |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2008
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5175454/ https://ncbi.nlm.nih.gov/pubmed/19128207 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|